Probiotic Interventions in Systemic Sclerosis Patients: A Systematic Review and Future Prospects
Zahra Mirfeizi1, Mahmoud Mahmoudi2,3, Marzieh Monemi4
1Rheumatology Department, Rheumatic Diseases Research Center Mashhad University of Medical Sciences Mashhad Iran.
Background And Aims:
Systemic sclerosis (SSc) is an uncommon autoimmune connective tissue disease distinguished by fibrosis and vascular abnormalities, often leading to gastrointestinal problems. This review explores the potential of probiotics in managing SSc-related gastrointestinal issues and modulating immune responses, highlighting the need for innovative treatments to improve patient well-being.
Methods:
We performed an extensive literature search up to October 2023 in databases, including Web of Science, PubMed/MEDLINE, and Scopus.
Result:
This review detected four articles that investigated the impact of probiotics on SSc. These studies, comprising non-randomized observational studies and randomized clinical trials, provide preliminary insights suggesting that probiotics may be efficacious in modulating the immune response and, consequently, in improving gastrointestinal symptoms in SSc patients.
Conclusion:
The comprehensive review suggests that probiotics may aid in managing gastrointestinal symptoms and modulating immune responses in SSc. However, it is essential to acknowledge the limited existing evidence, underscoring the need for more rigorous randomized controlled trials to thoroughly assess their effectiveness.
More Related Videos
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Probiotics
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease IV: Clinical Manifestations


